Organogenesis Holdings Inc.

Last updated September 27, 2026

Organization details

Legal name
Organogenesis Holdings Inc.
Former names
Avista Healthcare Public Acquisition Corp.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Canton
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
ORGO
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001661181

Board of directors

Chief executives

Gary S. Gillheeney · President and CEO
Dates unknown

Director election results

Annual meeting of June 15, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$40,100
2 purchases by 2 insiders
Sold, last 12 months
$2,620,120
4 sales by 1 insider
Date Insider Transaction Shares Price Value
Mar 9, 2026 Arthur S. Leibowitz Director Open-market purchase +5,000 $2.68 $13,400
Mar 9, 2026 Michael Joseph Driscoll Director Open-market purchase +10,000 $2.67 $26,700
Mar 1, 2026 Cavorsi Robert Officer (Vice President, Strategy) Shares withheld for tax −700 $3.21 $2,247
Feb 18, 2026 Freedman Lori Officer (Chief Admin. and Legal Officer) Grant or award +203,125 — —
Feb 18, 2026 Cavorsi Robert Officer (Vice President, Strategy) Grant or award +93,750 — —
Feb 18, 2026 Francisco David Officer (Chief Financial Officer) Grant or award +195,312 — —
Feb 18, 2026 Grow Brian Officer (Chief Commercial Officer) Grant or award +234,375 — —
Feb 18, 2026 Bilbo Patrick Officer (Chief Operating Officer) Grant or award +210,937 — —
Feb 18, 2026 Gary S. Gillheeney Director, Officer (President and CEO) Grant or award +890,625 — —
Feb 18, 2026 Michael Joseph Driscoll Director Grant or award +48,828 — —
Feb 18, 2026 Jon L. Giacomin Director Grant or award +48,828 — —
Feb 18, 2026 Arthur S. Leibowitz Director Grant or award +48,828 — —
Feb 18, 2026 Montecalvo Antonio S. Officer (Vice President, Health Policy) Grant or award +40,625 — —
Feb 18, 2026 Gilberto Quintero Director Grant or award +48,828 — —
Feb 18, 2026 Prathyusha Duraibabu Director Grant or award +48,828 — —

Organizations in the same sector, closest in location and size first.

Questions about Organogenesis Holdings Inc.

Who is the CEO of Organogenesis Holdings Inc.?

Gary S. Gillheeney is Organogenesis Holdings Inc.'s President and CEO.

How many directors are on Organogenesis Holdings Inc.'s board?

Organogenesis Holdings Inc.'s board has 10 directors: Alan A. Ades, Arthur S. Leibowitz, Garrett Lustig, Gary S. Gillheeney, Gilberto Quintero, Glenn H. Nussdorf, Jon L. Giacomin, Michael Joseph Driscoll, Michele Ilene Korfin and Prathyusha Duraibabu.

Are Organogenesis Holdings Inc. insiders buying or selling shares?

Over the last 12 months, Organogenesis Holdings Inc. insiders bought $40,100 of shares in 2 purchases and sold $2.6 million of shares in 4 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="organogenesis-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.